We have extended
approval, in concept, for the information collection requirements
associated with this regulation, which was proposed on December 17,
1991. Full approval will be granted upon publication of a final
rule that is fully responsive to the public comments received
regarding the proposed rule. FDA's response to comments should be
mor thorough than the tentative review provided with this
package.
Inventory as of this Action
Requested
Previously Approved
09/30/1994
09/30/1994
07/31/1993
1
0
1
1
0
1
0
0
0
TO FACILITATE A DETERMINATION AS TO
WHETHER THERE MAY BE GROUNDS FOR SUSPENDING OR WITHDRAWING APPROVAL
OF THE APPLICATION OR WHETHER ANY APPLICABLE REGULATION SHOULD BE
AMENDED OR REPEALED. THE RESPONDENTS ARE THE SPONSORS FOR APPROVED
NEW ANIMAL DRUG APPLICATIONS WHOSE_NUMBE HAVE INCREASED OVER THE
YEARS.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.